Data spanning the past 90 days through February 19, 2026 reveals that Wave Life Sciences's three principal insider shareholders consist of TenPercentOwner Plc Gsk (18.25Mn shares), Director Capital Management, L.P. Ra (18.20Mn shares), Director Ken Takanashi (5.73Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Plc Gsk | 18,245,691 | 15 Dec, 2025 | |
| Capital Management, L.P. Ra | 18,203,009 | 14 Nov, 2025 | |
| Ken Takanashi | 5,729,003 | 13 Aug, 2025 | |
| Chandra Vargeese | Nan | 408,246 | 11 Feb, 2026 |
| Paul Bolno | President And Ceo | 275,520 | 11 Feb, 2026 |
| Gregory L. Verdine | 275,217 | 10 Dec, 2025 | |
| Kyle Moran | Chief Financial Officer | 134,385 | 11 Feb, 2026 |
| Michael A. Panzara | Nan | 109,103 | 06 May, 2022 |
| Chris Francis | Nan | 61,867 | 11 Feb, 2026 |
| Heidi L Wagner | 44,930 | 10 Dec, 2025 | |
| Mark Corrigan | 28,815 | 10 Dec, 2025 | |
| Aik Na Tan | 25,400 | 10 Dec, 2025 | |
| Christian O Henry | 12,700 | 10 Dec, 2025 | |
| Adrian Rawcliffe | 12,700 | 10 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Feb, 2026 | Chandra Vargeese | Ordinary Shares | D | 3,228 | $13.45 | 408,246 | D | S |
| 09 Feb, 2026 | Chris Francis | Ordinary Shares | D | 1,883 | $13.45 | 61,867 | D | S |
| 09 Feb, 2026 | Paul Bolno | Ordinary Shares | D | 10,480 | $13.45 | 275,520 | D | S |
| 09 Feb, 2026 | Kyle Moran | Ordinary Shares | D | 3,588 | $13.45 | 134,385 | D | S |
| 05 Feb, 2026 | Chandra Vargeese | Ordinary Shares | A | 45,625 | $0.00 | 411,474 | D | A |
| 05 Feb, 2026 | Chris Francis | Ordinary Shares | A | 38,750 | $0.00 | 63,750 | D | A |
| 05 Feb, 2026 | Paul Bolno | Ordinary Shares | A | 165,000 | $0.00 | 286,000 | D | A |
| 05 Feb, 2026 | Kyle Moran | Ordinary Shares | A | 45,625 | $0.00 | 137,973 | D | A |
| 02 Jan, 2026 | Chris Francis | Ordinary Shares | D | 1,295 | $16.70 | 25,000 | D | S |
| 02 Jan, 2026 | Chris Francis | Ordinary Shares | D | 8,080 | $15.92 | 26,295 | D | S |
| 02 Jan, 2026 | Chris Francis | Ordinary Shares | A | 9,375 | $3.14 | 34,375 | D | M |
| 11 Dec, 2025 | Plc Gsk | Ordinary Shares | A | 1,470,000 | $19.00 | 18,245,691 | I | P |
| 11 Dec, 2025 | Plc Gsk | - | - | 18,245,691 | I | |||
| 09 Dec, 2025 | Kyle Moran | Ordinary Shares | A | 50,000 | $10.48 | 139,218 | D | M |
| 09 Dec, 2025 | Kyle Moran | Ordinary Shares | D | 50,000 | $20.02 | 90,365 | D | S |
| 09 Dec, 2025 | Kyle Moran | Ordinary Shares | D | 36 | $20.25 | 89,218 | D | S |
| 09 Dec, 2025 | Kyle Moran | Ordinary Shares | A | 36,000 | $8.17 | 125,218 | D | M |
| 08 Dec, 2025 | Mark Corrigan | Ordinary Shares | D | 6,515 | $14.06 | 28,815 | D | S |
| 08 Dec, 2025 | Mark Corrigan | Ordinary Shares | D | 9,600 | $13.09 | 35,330 | D | S |
| 08 Dec, 2025 | Christian O Henry | Ordinary Shares | A | 15,000 | $3.50 | 27,700 | D | M |